| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | 2.16.840.1.113762.1.4.1248.119 |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1248.119/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1248.119 |
| Version | 20250211 |
| Status | active |
| Date | 2025-02-11T01:03:34-05:00 |
| Name | OpioidAntagonist |
| Title | Opioid Antagonist |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: The purpose of this value set is to represent concepts for the opioid antagonist medications naloxone and nalmefine administered to reverse over-administration of opioids in the hospital setting),(Data Element Scope: This value set may use a model element related to Medication),(Inclusion Criteria: Includes concepts that represent non-enteral (intranasal, intramuscular, intravenous, subcutaneous, inhalation) forms of naloxone and nalmefene medications),(Exclusion Criteria: Excludes all other types of opioid antagonists such as naltrexone. Excludes combination medications that contain both an opioid antagonist and an opioid. Excludes concepts that represent enteral (e.g., oral, gastrointestinal) forms of naloxone and nalmefene medications.) |
No resources found
| CodeSystem | |
| rxnorm | RxNorm |
| rxnorm | RxNorm |
No narrative content found in resource
FHIR